Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Lenzi

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Annals of the New York Academy of Sciences|September 7, 2007
Role of the HLA class II: HCV-related disordersValli De Re, Laura Caggiari, Maria Paola Simula, et al.
Clinical and Translational Science|September 29, 2020
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?Simona Pascolini, Antonio Vannini, Gaia Deleonardi, et al.
Journal of Hepatology|January 23, 2022
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis GroupSimon Pape, Romée J A L M Snijders, Tom J G Gevers, et al.
Journal of Autoimmunity|August 10, 2015
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre studyLuca Quartuccio, Francesca Zuliani, Laura Corazza, et al.
Clinical and Experimental Rheumatology|March 14, 2012
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitisLuca Quartuccio, Miriam Isola, Laura Corazza, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Annals of the New York Academy of Sciences|September 7, 2007
Role of the HLA class II: HCV-related disordersValli De Re, Laura Caggiari, Maria Paola Simula, et al.
Clinical and Translational Science|September 29, 2020
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?Simona Pascolini, Antonio Vannini, Gaia Deleonardi, et al.
Journal of Hepatology|January 23, 2022
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis GroupSimon Pape, Romée J A L M Snijders, Tom J G Gevers, et al.
Journal of Autoimmunity|August 10, 2015
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre studyLuca Quartuccio, Francesca Zuliani, Laura Corazza, et al.
Clinical and Experimental Rheumatology|March 14, 2012
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitisLuca Quartuccio, Miriam Isola, Laura Corazza, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Pageof 7